{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:16:34Z","timestamp":1793902594610,"version":"4.8.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>\n                      Lower allograft survival has been demonstrated in kidney transplant recipients without HIV whose donors have 2 apolipoprotein L1 (\n                      <jats:italic toggle=\"yes\">APOL1<\/jats:italic>\n                      ) renal risk variants (RRVs). The effects of\n                      <jats:italic toggle=\"yes\">APOL1<\/jats:italic>\n                      RRV on kidney transplant outcomes in people with HIV have not been fully assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>\n                      Genomic DNA was analyzed for\n                      <jats:italic toggle=\"yes\">APOL1<\/jats:italic>\n                      RRV genotype using a probe-based assay in HIV-positive kidney transplant recipients (R\n                      <jats:sup>+<\/jats:sup>\n                      ) and their respective HIV-negative (D\n                      <jats:sup>\u2212<\/jats:sup>\n                      ) or HIV-positive (D\n                      <jats:sup>+<\/jats:sup>\n                      ) kidney donors participating in HIV transplantation studies in South Africa (SA) and the United States (US). Allograft outcomes (time to first rejection, HIV-associated nephropathy, graft failure, or death) were compared by both donor and recipient RRV status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Genomic DNA was available for 21 donors with HIV and 38 HIV D\n                      <jats:sup>+<\/jats:sup>\n                      \/R\n                      <jats:sup>+<\/jats:sup>\n                      recipients in the SA cohort, and 57 donors (40 D\n                      <jats:sup>+<\/jats:sup>\n                      and 17 D\n                      <jats:sup>\u2212<\/jats:sup>\n                      ) and 119 recipients (49 HIV D\n                      <jats:sup>+<\/jats:sup>\n                      \/R\n                      <jats:sup>+<\/jats:sup>\n                      and 70 D\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/R\n                      <jats:sup>+<\/jats:sup>\n                      ) in the US cohort. Recipient outcomes were not associated with recipient\n                      <jats:italic toggle=\"yes\">APOL1<\/jats:italic>\n                      genotype. However, recipients whose donor carried 1 versus 0\n                      <jats:italic toggle=\"yes\">APOL1<\/jats:italic>\n                      RRV were significantly more likely to experience a negative composite outcome (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.02 for both cohorts independently), which led to an adjusted hazard ratio of a poor composite outcome of 2.9 (95% confidence interval, 1.1 to 7.4) and 10.1 (95% confidence interval, 2.4 to 42.7) in the SA and US cohorts, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>\n                      In two independent cohorts, the presence of 1\n                      <jats:italic toggle=\"yes\">APOL1<\/jats:italic>\n                      RRV in a donor kidney led to significantly worse posttransplant outcomes. Further research into the interaction between the allograft environment and donor\n                      <jats:italic toggle=\"yes\">APOL1<\/jats:italic>\n                      genotype in people with HIV is required.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005556","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:00:08Z","timestamp":1763398808000},"page":"e897-e904","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["APOL1 Genotype and Patient Outcomes in US and South African Transplant Recipients With HIV who Received Kidneys From Donors With HIV"],"prefix":"10.1097","volume":"110","author":[{"given":"Robert","family":"Freercks","sequence":"first","affiliation":[{"name":"Faculty of Health Sciences, Department of Medicine, Nelson Mandela University, Gqeberha, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moreno","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Manning","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Cape Town, Cape Town, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Heymann","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, NIDDK, NIH, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Kopp","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, NIDDK, NIH, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savania","family":"Nagiah","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Department of Medicine, Nelson Mandela University, Gqeberha, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Rana","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mount Sinai School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Florman","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mount Sinai School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Friedman-Moraco","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stock","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California San Francisco, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Department of Surgery, Georgetown University, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Alabama Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Stosor","sequence":"additional","affiliation":[{"name":"Department of Surgery, Northwestern University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus R.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele I.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Miami, Miami, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hand","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ochsner Medical Center, New Orleans, LA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghady","family":"Haidar","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricar","family":"Malinis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A. Q.","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rush University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Schaenman","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Blumberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wojciechowski","sequence":"additional","affiliation":[{"name":"Department of Medicine, UT Southwestern Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah","family":"Odim","sequence":"additional","affiliation":[{"name":"Transplantation Branch, NIAID, NIH, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Massie","sequence":"additional","affiliation":[{"name":"Department of Surgery, New York University, New York City, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miruthula Tamil","family":"Selvan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Bagnasco","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorry","family":"Segev","sequence":"additional","affiliation":[{"name":"Department of Surgery, New York University, New York City, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A. R.","family":"Tobian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmi","family":"Muller","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Cape Town, Cape Town, South Africa."},{"name":"Faculty of Medicine, Stellenbosch University, Cape Town, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Durand","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Redd","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University, Baltimore, MD."},{"name":"Division of Intramural Research, NIAID, NIH, Baltimore, MD."},{"name":"Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"R1-20260521","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1408896","article-title":"HIV-positive-to-HIV-positive kidney transplantation\u2014results at 3 to 5 years.","volume":"372","author":"Muller","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-20260521","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJMoa2403733","article-title":"Safety of kidney transplantation from donors with HIV.","volume":"391","author":"Durand","year":"2024","journal-title":"N Engl J Med"},{"key":"R3-20260521","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJMe2411549","article-title":"HIV-Positive organ donation as standard of care in transplantation.","volume":"391","author":"Muller","year":"2024","journal-title":"N Engl J Med"},{"key":"R4-20260521","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/TP.0000000000004857","article-title":"Wait time advantage for transplant candidates with HIV who accept kidneys from donors with HIV under the HOPE Act.","volume":"108","author":"Motter","year":"2024","journal-title":"Transplantation"},{"key":"R5-20260521","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans.","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"R7-20260521","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2404211","article-title":"APOL1 Bi-and monoallelic variants and chronic kidney disease in West Africans.","volume":"392","author":"Gbadegesin","year":"2024","journal-title":"N Engl J Med"},{"key":"R8-20260521","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5301\/jn.5000179","article-title":"Population genetics of chronic kidney disease: the evolving story of APOL1.","volume":"25","author":"Wasser","year":"2012","journal-title":"J Nephrol"},{"key":"R9-20260521","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease.","volume":"22","author":"Friedman","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R10-20260521","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.14321121","article-title":"Apolipoprotein L1 high-risk genotypes and albuminuria in sub-Saharan African populations.","volume":"17","author":"Brandenburg","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-20260521","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.0000000000000219","article-title":"Genetic inhibition of APOL1 pore-forming function prevents APOL1-mediated kidney disease.","volume":"34","author":"Hung","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"R12-20260521","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/TP.0000000000002509","article-title":"Mechanisms of injury in APOL1-associated kidney disease.","volume":"103","author":"Ma","year":"2019","journal-title":"Transplantation"},{"key":"R13-20260521","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrmicro3449","article-title":"HIV-1 and interferons: who\u2019s interfering with whom?","volume":"13","author":"Doyle","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"R14-20260521","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.amjmed.2008.11.021","article-title":"White\/Black racial differences in risk of end-stage renal disease and death.","volume":"122","author":"Choi","year":"2009","journal-title":"Am J Med"},{"key":"R15-20260521","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.kint.2021.03.030","article-title":"APOL1 genotyping in kidney transplantation: a look into the future.","volume":"100","author":"Madhavan","year":"2021","journal-title":"Kidney Int"},{"key":"R16-20260521","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMc1903013","article-title":"Longer-Term outcomes of HIV-positive-to-HIV-positive renal transplantation.","volume":"381","author":"Selhorst","year":"2019","journal-title":"N Engl J Med"},{"key":"R17-20260521","first-page":"140","article-title":"Clinical course, management and outcomes of COVID-19 in HIV-infected renal transplant recipients: a case series.","volume":"114","author":"Bertels","year":"2024","journal-title":"S Afr Med J"},{"key":"R18-20260521","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R19-20260521","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000529227","article-title":"APOL1 and APOL1-associated kidney disease: a common disease, an unusual disease gene\u2013proceedings of the henry shavelle professorship.","volume":"3","author":"Pollak","year":"2023","journal-title":"Glomerular Dis"},{"key":"R20-20260521","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors.","volume":"100","author":"Freedman","year":"2016","journal-title":"Transplantation"},{"key":"R21-20260521","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021119-034345","article-title":"APOL1 and kidney disease: from genetics to biology.","volume":"82","author":"Friedman","year":"2020","journal-title":"Annu Rev Physiol"},{"key":"R22-20260521","doi-asserted-by":"crossref","first-page":"e14234","DOI":"10.1111\/ctr.14234","article-title":"Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation.","volume":"35","author":"Chen","year":"2021","journal-title":"Clin Transplant"},{"key":"R23-20260521","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1681\/ASN.2015111220","article-title":"APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease.","volume":"27","author":"Bruggeman","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R24-20260521","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3390\/cells10081914","article-title":"Novel human podocyte cell model carrying G2\/G2 APOL1 high-risk genotype.","volume":"10","author":"Ekulu","year":"2021","journal-title":"Cells"},{"key":"R25-20260521","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.kint.2023.03.035","article-title":"Hypoxia hits APOL1 in the kidney.","volume":"104","author":"Grampp","year":"2023","journal-title":"Kidney Int"},{"key":"R26-20260521","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans.","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R27-20260521","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.semnephrol.2017.07.004","article-title":"APOL1 renal risk variants: fertile soil for HIV-associated nephropathy.","volume":"37","author":"Kopp","year":"2017","journal-title":"Semin Nephrol"},{"key":"R28-20260521","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/cid\/ciu765","article-title":"The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.","volume":"60","author":"Estrella","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R29-20260521","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"R30-20260521","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12977-016-0296-3","article-title":"Impact of APOL1 polymorphism and IL-1\u03b2 priming in the entry and persistence of HIV-1 in human podocytes.","volume":"13","author":"Mikulak","year":"2016","journal-title":"Retrovirology"},{"key":"R31-20260521","doi-asserted-by":"crossref","first-page":"114310","DOI":"10.1016\/j.celrep.2024.114310","article-title":"Interferon-\u03b3 induces combined pyroptotic angiopathy and APOL1 expression in human kidney disease.","volume":"43","author":"Juliar","year":"2024","journal-title":"Cell reports"},{"key":"R32-20260521","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.kint.2018.06.024","article-title":"Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.","volume":"94","author":"Santoriello","year":"2018","journal-title":"Kidney Int"},{"key":"R33-20260521","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jamainternmed.2021.8538","article-title":"APOL1 risk variants, acute kidney injury, and death in participants with African ancestry hospitalized with COVID-19 from the Million Veteran Program.","volume":"182","author":"Hung","year":"2022","journal-title":"JAMA Internal Med"},{"key":"R34-20260521","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation.","volume":"11","author":"Reeves\u2010Daniel","year":"2011","journal-title":"Am J Transplant"},{"key":"R35-20260521","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5\u2010year allograft survival.","volume":"12","author":"Lee","year":"2012","journal-title":"Am J Transplant"},{"key":"R36-20260521","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1097\/TP.0000000000004742","article-title":"Association of recipient APOL1 kidney risk alleles with kidney transplant outcomes.","volume":"107","author":"Roy","year":"2023","journal-title":"Transplantation"},{"key":"R37-20260521","doi-asserted-by":"crossref","first-page":"e146643","DOI":"10.1172\/JCI146643","article-title":"Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes.","volume":"131","author":"Zhang","year":"2021","journal-title":"J Clin Invest"},{"key":"R38-20260521","doi-asserted-by":"crossref","first-page":"106830","DOI":"10.1016\/j.isci.2023.106830","article-title":"APOL1 promotes endothelial cell activation beyond the glomerulus.","volume":"26","author":"Carracedo","year":"2023","journal-title":"Iscience"},{"key":"R39-20260521","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.01510218","article-title":"The APOL1 long-term kidney transplantation outcomes network\u2014APOLLO.","volume":"13","author":"Freedman","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R40-20260521","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/v16081205","article-title":"Relationship between modern ART regimens and immunosenescence markers in patients with chronic HIV infection.","volume":"16","author":"Grozdeva","year":"2024","journal-title":"Viruses"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:00:33Z","timestamp":1779382833000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005556","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]}}}